[Form 4] VISA Inc. Insider Trading Activity
Peter M. Andreski, Visa Inc. officer (GBL Corp Controller, CAO), reported equity transactions on Form 4 filed August 19, 2025. The filing shows 4,169 restricted stock units (RSUs) treated as acquired under Code M and reflected as 4,169 underlying shares, and a separate non-derivative sale of 1,688 Class A common shares at $344.47 each. After the reported transactions, the filing indicates beneficial ownership counts of 8,657 and 6,969 shares in the non-derivative table and 4,170 derivative shares beneficially owned. The RSUs were originally granted on August 15, 2023 and vest 50% on the second grant anniversary and 50% on the third, with limited earlier vesting circumstances as described in the award agreement.
- Detailed disclosure of RSU grant and vesting schedule (grant date August 15, 2023; 50% vests on year 2 and 50% on year 3)
- Sale price provided for disposed shares ($344.47 for 1,688 Class A shares), aiding transparency
- None.
Insights
TL;DR: Insider reported a grant of RSUs and a sale of shares, leaving modest net change in beneficial ownership.
The Form 4 discloses a grant-related transaction (Code M) for 4,169 RSUs and a contemporaneous open-market or other sale (Code F) of 1,688 Class A shares at $344.47. Code M indicates conversion/vesting/reporting of previously granted awards rather than a purchased open-market acquisition. The RSU grant date is August 15, 2023, with scheduled vesting over the second and third anniversaries, so the reported RSUs remain subject to future vesting conditions. The filing was executed by an attorney-in-fact and shows remaining beneficial ownership in both non-derivative and derivative categories. For investors, this is a routine executive compensation-related disclosure rather than an unusual liquidity event.
TL;DR: Disclosure aligns with standard executive award reporting and contains vesting schedule details.
The report clearly identifies the reporting person’s role, the nature of the RSUs, and the vesting timetable tied to the August 15, 2023 grant. The separate sale of 1,688 shares at $344.47 is itemized with resulting share counts. Signature by an attorney-in-fact is present and dated August 19, 2025. There are no statements of acceleration, forfeiture, or unusual derivative instruments disclosed. This filing appears consistent with routine compensation administration and required Section 16 reporting obligations.